Millennium Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Millennium Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-200,000	Closed	-$1.17M	–	4011
2015 Q3	$1.17M	Sell	200,000 -200,000	-50%	-$1.54M	﹤0.01%	2205
2015 Q2	$3.31M	Buy	400,000 +200,000	+100%	+$1.77M	0.01%	1631
2015 Q1	$1.65M	Buy	200,000 +99,600	+99%	+$736K	﹤0.01%	2059
2014 Q4	$690K	Buy	+100,400	New	+$628K	﹤0.01%	2773
2014 Q3	–	Sell	-200,000	Closed	-$1.27M	–	4218
2014 Q2	$1.27M	Buy	+200,000	New	+$1.38M	﹤0.01%	2053

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Millennium Management's ARIA Position: Q1 2017 in Review

Millennium Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 250,925 shares — an estimated $3.12M sold.

Millennium Management first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $13.6M in Q1 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Millennium Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Millennium Management sold 250,925 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $3.12M.
Millennium Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
Millennium Management's Ariad Pharmaceuticals Inc position peaked at $13.6M in Q1 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.